Abstract
Cystic echinococcosis is parasitic disease due to the larval stage of the metacestode Echinococcus granulosus in the liver (80%), lungs, kidneys, spleen, myocardium etc. Humans are accidental intermediate hosts. Diagnosis is based on laboratory and imaging studies. Treatment is multimodal, surgical and medical. Risks for dangerous complications and relapses are quite common. Adequate follow-up is needed. Albendazole has a central role in the medical therapy of the disease.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Albendazole / administration & dosage*
-
Animals
-
Anticestodal Agents / administration & dosage*
-
Drug Administration Schedule
-
Echinococcosis / diagnosis
-
Echinococcosis / drug therapy*
-
Echinococcosis / surgery*
-
Echinococcus granulosus* / drug effects
-
Echinococcus granulosus* / isolation & purification
-
Humans
-
Laparoscopy
-
Minimally Invasive Surgical Procedures*
-
Risk Factors
-
Time Factors
-
Treatment Outcome
Substances
-
Anticestodal Agents
-
Albendazole